New Buyers, New Motivations: Foreign Firms Join The US Biotech Buying Frenzy

New Buyers, New Motivations: Foreign Firms Join The US Biotech Buying Frenzy

Upworthy

Published

The depreciated value of US biotechnology companies has not gone unnoticed by traditional pharmaceutical conglomerates looking to augment their pipelines at attractive prices. Merck (Imago), Johnson & Johnson (Abiomed) and Astra Zeneca (Neogene) each announced definitive agreements to acquire US…

#johnsonjohnson #astrazeneca #mumbai #massachusetts #sunpharma #concert #aveopharmaceuticals #lgchemlifesciences #korean #lgcorporation

Full Article